Wells Fargo & Company Brickell Biotech, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
N/A
11 Added 7.69%
154 $0
Q2 2023

Aug 15, 2023
BUY
N/A
23 Added 19.17%
143 $0
Q1 2023

May 12, 2023
BUY
N/A
2 Added 1.69%
120 $0
Q4 2022

Feb 13, 2023
BUY
$1.71 - $2.08 $1 - $2
1 Added 0.85%
118 $0
Q3 2022

Nov 14, 2022
BUY
$1.72 - $4.41 $201 - $515
117 New
117 $0

Others Institutions Holding BBI

# of Institutions
1
Shares Held
65K
Call Options Held
0
Put Options Held
0
View Full List

About Brickell Biotech, Inc.

BBI Quotes by TradingView
  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email